Genmab — August 2017
-
Jeg tror ikke denne her har været fremme. De 29% ORR i mono Dara RRMM (de første studier) er nu blevet til 67% chance for overlevelse. Det kan ikke end gang NICE komme uden om
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518219/ -
Bongo: Plesner er lidt inde på det samme i beg. af dette interview fra juni. Patienterne lever længere med "stable disease" efter monoterapi. https://www.youtube.com/watch?v=RaewRYsZHkA&t=76s
-
Det har jeg Raffles...Tak for dem.

-
Hvornår kom regnskabet i morgen?
Før eller efter børsåbning? -
A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma https://clinicaltrials.gov/show/NCT03242889
-
Regnskabet kommer efter luk.

-
God morgen.

-
Go morgen.. Taget fra dara debatside, på facebook.My numbers all went down fast with Dara alone and also have continued to stay down. Just had my 18th infusion. My m protein has been undetectable since about 4th infusion. So very thankful!..
-
Tak Transalp.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind